Call for papers - Cell-Based therapeutics in human disease

Guest Editors

Yan Ma, PhD, National Institute of Neurological Disorders and Stroke, USA
Mohd Hussain Shah, PhD, National Eye Institute (NEI), USA
Meijie Tian, PhD, National Cancer Institute (NCI), USA

Submission Status: Open | Submission Deadline: 18 April 2025

BMC Medical Genomics is calling for submissions to our Collection on Cell-Based therapeutics in human disease.

This collection aims to bridge the gap between basic and clinical research in cell-based therapies and to facilitate the efficient translation of research from bench to bedside. We invite submissions of original studies on the characterization and utilization of cells in preclinical and clinical therapies., molecular strategies to enhance cell-based therapeutic function, and clinical applications of cell-based therapies.

Submit to Collection

Meet the Guest Editors

Back to top

Yan Ma, PhD, National Institute of Neurological Disorders and Stroke, USA

Dr Yan Ma is a research associate in the Spatial Navigation and Memory Unit, National Institute of Neurological Disorders and Stroke (NINDS). Her current research revolves around investigating the intricate functions of the medial entorhinal cortex (MEC) in spatial memory, particularly its implications in Alzheimer’s disease (AD), and utilizing a comprehensive array of methodologies, including optical imaging, behavioral analysis, computational modeling, and molecular techniques, for understanding the dynamic interplay within the MEC.

Mohd Hussain Shah, PhD, National Eye Institute (NEI), USA

Dr Mohd Hussain Shah works at the National Eye Institute (NEI) as a research fellow to pursue further research in the field of ocular genetic disorders and explore the regulation of crystallin’s genes in chick lens epithelial cells and lens development in chick embryos.

Meijie Tian, PhD, Center of Cancer Research, National Cancer Institute (NCI), USA

Dr Meijie Tian is a NIH-funded researcher in the Oncogenomic Section at the Genetics Branch, Center of Cancer Research, National Cancer Institute (NCI), focusing on developing cell therapies for pediatric solid tumors using CAR T cells, including neuroblastoma and rhabdomyosarcoma.

About the Collection

BMC Medical Genomics is calling for submissions to our Collection on Cell-Based therapeutics in human disease.

Cell-based therapies offer unparalleled potential to reprogram cellular functions to address patient-specific and disease-specific needs. These therapeutics have transformed clinical practice and provide novel avenues for personalized medicine. Some ground-breaking treatments, such as reprogrammed T cells for cancer treatment and adipose-derived stem cells for Crohn’s disease have demonstrated the potential for cell-based therapeutics. These advancements were made possible by interdisciplinary research, combining fundamental biomedical science with cutting-edge engineering technologies.

This collection aims to bridge the gap between basic and clinical research in cell-based therapies and to facilitate the efficient translation of research from bench to bedside. We invite submissions of original studies on the characterization and utilization of cells in preclinical and clinical therapies., molecular strategies to enhance cell-based therapeutic function, and clinical applications of cell-based therapies.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Cell-Based therapeutics in human disease" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.